{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Amonafide_L-Malate",
  "nciThesaurus": {
    "casRegistry": "618863-54-0",
    "chebiId": "",
    "chemicalFormula": "C16H17N3O2.C4H6O5",
    "definition": "The malate salt of amonafide, an imide derivative of naphthalic acid, with potential antineoplastic activity. Amonafide intercalates into DNA and inhibits topoisomerase II, resulting in DNA double-strand breaks (DSB) and inhibition of DNA replication and RNA synthesis.",
    "fdaUniiCode": "LI06Q37TEG",
    "identifier": "C61306",
    "preferredName": "Amonafide L-Malate",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C582"
    ],
    "synonyms": [
      "5-amino-2-[2-(dimethylamino)ethyl]-1H-benz[de]isoquinoline-1,3(2H)-dione (2S)-2-ydroxybutanedioate",
      "AMONAFIDE L-MALATE",
      "AS1413",
      "Amonafide L-Malate",
      "Butanedioic Acid, 2-hydroxy-, (2S)-, compd. with 5-amino-2-(2-(dimethylamino)ethyl)-1h-benz[de]isoquinoline-1,3(2h)-dione (1:1)",
      "XAN-02",
      "Xanafide"
    ]
  }
}